BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 23944368)

  • 21. Many si/shRNAs can kill cancer cells by targeting multiple survival genes through an off-target mechanism.
    Putzbach W; Gao QQ; Patel M; van Dongen S; Haluck-Kangas A; Sarshad AA; Bartom ET; Kim KA; Scholtens DM; Hafner M; Zhao JC; Murmann AE; Peter ME
    Elife; 2017 Oct; 6():. PubMed ID: 29063830
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of CD95 (Apo-1/Fas) ligand and receptor expression in squamous-cell carcinoma by interferon-gamma and cisplatin.
    Moers C; Warskulat U; Müschen M; Even J; Niederacher D; Josien R; Koldovsky U; Beckmann MW; Häussinger D
    Int J Cancer; 1999 Feb; 80(4):564-72. PubMed ID: 9935158
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential and mutually exclusive expression of CD95 and CD95 ligand in epithelia of normal pancreas and chronic pancreatitis.
    Hasel C; Rau B; Perner S; Sträter J; Möller P
    Lab Invest; 2001 Mar; 81(3):317-26. PubMed ID: 11310825
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitation of CD95 and CD95L mRNA expression in chronic and acute HIV-1 infection by competitive RT-PCR.
    Pinti M; Nasi M; Moretti L; Mussini C; Petrusca D; Esposito R; Cossarizza A
    Ann N Y Acad Sci; 2000; 926():46-51. PubMed ID: 11193040
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Innate immunity in the Grid2Lc/+ mouse model of cerebellar neurodegeneration: glial CD95/CD95L plays a non-apoptotic role in persistent neuron loss-associated inflammatory reactions in the cerebellum.
    Vernet-der Garabedian B; Derer P; Bailly Y; Mariani J
    J Neuroinflammation; 2013 May; 10():65. PubMed ID: 23672668
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nonapoptotic functions of Fas/CD95 in the immune response.
    Guégan JP; Legembre P
    FEBS J; 2018 Mar; 285(5):809-827. PubMed ID: 29032605
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Generation and Application of Bioluminescent CD95 Ligand Fusion Proteins.
    Lang I; Kums J; Wajant H
    Methods Mol Biol; 2017; 1557():63-77. PubMed ID: 28078583
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of drug-induced activation of the CD95 apoptotic pathway in a cisplatin-resistant testicular germ cell tumor cell line.
    Spierings DC; de Vries EG; Vellenga E; de Jong S
    Cell Death Differ; 2003 Jul; 10(7):808-22. PubMed ID: 12815464
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD95 ligand induces senescence in mismatch repair-deficient human colon cancer via chronic caspase-mediated induction of DNA damage.
    Raats DA; Frenkel N; van Schelven SJ; Rinkes IH; Laoukili J; Kranenburg O
    Cell Death Dis; 2017 Mar; 8(3):e2669. PubMed ID: 28300842
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD95 ligand is a proliferative and antiapoptotic signal in quiescent hepatic stellate cells.
    Reinehr R; Sommerfeld A; Häussinger D
    Gastroenterology; 2008 May; 134(5):1494-506. PubMed ID: 18471522
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD95-mediated cell signaling in cancer: mutations and post-translational modulations.
    Tauzin S; Debure L; Moreau JF; Legembre P
    Cell Mol Life Sci; 2012 Apr; 69(8):1261-77. PubMed ID: 22042271
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD95/Fas and metastatic disease: What does not kill you makes you stronger.
    Guégan JP; Ginestier C; Charafe-Jauffret E; Ducret T; Quignard JF; Vacher P; Legembre P
    Semin Cancer Biol; 2020 Feb; 60():121-131. PubMed ID: 31176682
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD95 and CD95L promote and protect cancer stem cells.
    Ceppi P; Hadji A; Kohlhapp FJ; Pattanayak A; Hau A; Liu X; Liu H; Murmann AE; Peter ME
    Nat Commun; 2014 Nov; 5():5238. PubMed ID: 25366259
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential down-regulation of CD95 or CD95L in chronically HIV-infected cells of monocytic or lymphocytic origin: cellular studies and molecular analysis by quantitative competitive RT-PCR.
    Pinti M; Pedrazzi J; Benatti F; Sorrentino V; Nuzzo C; Cavazzuti V; Biswas P; Petrusca DN; Mussini C; De Rienzo B; Cossarizza A
    FEBS Lett; 1999 Sep; 458(2):209-14. PubMed ID: 10481067
    [TBL] [Abstract][Full Text] [Related]  

  • 35. p53 enhances BAK and CD95 expression in human malignant glioma cells but does not enhance CD95L-induced apoptosis.
    Pohl U; Wagenknecht B; Naumann U; Weller M
    Cell Physiol Biochem; 1999; 9(1):29-37. PubMed ID: 10352342
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD95 (APO-1/Fas)-mediated apoptosis in colon epithelial cells: a possible role in ulcerative colitis.
    Sträter J; Wellisch I; Riedl S; Walczak H; Koretz K; Tandara A; Krammer PH; Möller P
    Gastroenterology; 1997 Jul; 113(1):160-7. PubMed ID: 9207274
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The CD95/CD95 ligand system is not the major effector in anticancer drug-mediated apoptosis.
    Tolomeo M; Dusonchet L; Meli M; Grimaudo S; D'Alessandro N; Papoff G; Ruberti G; Rausa L
    Cell Death Differ; 1998 Sep; 5(9):735-42. PubMed ID: 10200532
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The CD95(APO-1/Fas)/CD95L system.
    Krammer PH
    Toxicol Lett; 1998 Dec; 102-103():131-7. PubMed ID: 10022244
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A CD40-CD95L fusion protein interferes with CD40L-induced prosurvival signaling and allows membrane CD40L-restricted activation of CD95.
    Assohou-Luty C; Gerspach J; Siegmund D; Müller N; Huard B; Tiegs G; Pfizenmaier K; Wajant H
    J Mol Med (Berl); 2006 Sep; 84(9):785-97. PubMed ID: 16924474
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tyrosine phosphorylation and CD95: a FAScinating switch.
    Sancho-Martinez I; Martin-Villalba A
    Cell Cycle; 2009 Mar; 8(6):838-42. PubMed ID: 19221505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.